Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials

Cervical cancer constitutes a significant health burden for women globally. While most patients with early-stage disease can be cured with radical surgery or chemoradiotherapy, patients with high-risk locally advanced disease or with recurrent/metastatic disease have a poor prognosis with standard t...

Descripción completa

Detalles Bibliográficos
Autores principales: Monk, Bradley J., Enomoto, Takayuki, Kast, W. Martin, McCormack, Mary, Tan, David S.P., Wu, Xiaohua, González-Martín, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697630/
https://www.ncbi.nlm.nih.gov/pubmed/35413489
http://dx.doi.org/10.1016/j.ctrv.2022.102385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697630/
https://www.ncbi.nlm.nih.gov/pubmed/35413489
http://dx.doi.org/10.1016/j.ctrv.2022.102385

Ejemplares similares